NCT07354893

Brief Summary

The absence or dysfunction of the spleen is associated with a substantially increased risk of invasive infections that may rapidly progress to fulminant sepsis, including overwhelming post-splenectomy infection (OPSI), a medical emergency with high mortality. Although the risk is greatest in the first two years after splenectomy, it persists lifelong. Preventing infections in patients with anatomical or functional asplenia requires an integrated strategy that includes patient education, early recognition of symptoms, behavioral measures, antibiotic prophylaxis when indicated, and vaccination. Post-splenectomy immunization has been shown to reduce OPSI incidence. Regional and international guidelines recommend vaccination against pneumococcus, Haemophilus influenzae type b, meningococcus (B and ACWY), herpes zoster, diphtheria-tetanus-pertussis, measles-mumps-rubella-varicella, and annual influenza. However, adherence to these recommendations is frequently suboptimal, often due to limited awareness among patients and healthcare professionals. This study involves the intra-hospital vaccination team providing structured vaccination consultations to splenectomized patients hospitalized at the Fondazione Policlinico Universitario "A. Gemelli" IRCCS. During ward consultations, patients receive an educational intervention on asplenia-related infectious risks and preventive measures, supported by standardized informational materials. Effectiveness is evaluated using a pre-post questionnaire assessing knowledge and awareness. Patients completing the vaccination pathway at the outpatient clinic also complete a questionnaire assessing their experience with vaccination management in an intra-hospital setting.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Jan 2026

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Jan 2026Jan 2028

First Submitted

Initial submission to the registry

January 12, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

January 13, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2028

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

January 12, 2026

Last Update Submit

January 29, 2026

Conditions

Keywords

OPSIinfection riskInfection PreventionPreventive measuresVaccinationaspleniasplenectomysplenectomized patientspost splenectomy infections

Outcome Measures

Primary Outcomes (1)

  • Change in Infectious Risk Knowledge, Vaccination Attitudes, and Risk Perception Score

    Change from baseline to post-intervention in patients' knowledge of infectious risk, attitudes toward vaccination, and perception of infectious risk following an educational and counseling intervention. The outcome is assessed in splenectomized patients identified and/or managed by the intra-hospital outpatient clinic of the Fondazione Policlinico Universitario "A. Gemelli" IRCCS (FPG). Measure Description: Infectious Risk and Vaccination Awareness Questionnaire for Splenectomized Patients (specifically developed and validated questionnaire). The total score ranges from 16 to 80, with higher scores indicating greater knowledge, more favorable attitudes toward vaccination, and higher perceived infectious risk.

    24 months

Secondary Outcomes (3)

  • Patient Experience with Vaccination Prophylaxis Management Score

    24 months

  • Association Between Infectious Risk Knowledge Score and Socio-demographic Characteristics

    24 months

  • Adherence to the Intra-hospital Vaccination Pathway

    24 months

Interventions

an educational intervention aimed at informing patients about the condition of asplenia, the associated infectious risks, and the main preventive measures, with particular emphasis on vaccination prophylaxis. To support the intervention, educational materials will be distributed, including an informational brochure and the "Recommended Vaccinations for Asplenic Patients" schedule.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients splenectomized at the Fondazione Policlinico Universitario A. Gemelli IRCCS, identified during consultation activities in the requesting wards and/or managed by the hospital outpatient vaccination clinic for frail patients.

You may qualify if:

  • Adult patients (≥18 years old)
  • Patients splenectomized at FPG for whom a vaccination consultation is requested during hospitalization
  • Patients who provide signed informed consent to participate in the study and for the processing of personal data for research purposes

You may not qualify if:

  • Minor patients
  • Lack of signed informed consent for participation in the study and for the processing of personal data for research purposes
  • Patients splenectomized at other healthcare facilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Rome, Lazio, 00168, Italy

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, 00168, Italy

RECRUITING

Study Officials

  • LAURENTI PATRIZIA, PROFESSOR

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

LAURENTI PATRIZIA, PROFESSOR

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
24 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 12, 2026

First Posted

January 21, 2026

Study Start

January 13, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

January 13, 2028

Last Updated

February 2, 2026

Record last verified: 2026-01

Locations